🧠 Join us @uzh-ch.bsky.social ! We are a new lab looking for PhDs, Postdocs & Master’s students interested in studying how human neural systems emerge & go awry using brain organoids, light-sheet imaging & genomics. 🚀 Deadline for LSZGS 1st Nov! www.lifescience-graduateschool.uzh.ch/en.html.
Looking for a PhD student in cancer biology.
Project: Oncoembryology – targeting reactivated embryonic programs in cancer.
Application via Life Science Zurich Graduate School
Deadline: 1 Nov 2025.
👉 Full details here: www.linkedin.com/posts/hassan...
#PhD #CancerBiology #Oncoembryology #Zurich
New perspective in selecting cancer treatment can provide more precision by targeting resurrect embryonic genetic (oncoembryonic) programs that fuel malignancy, metastasis, immune suppression, and therapy resistance.
#oncoembryology #cancerresearch #precisionmedicine
It is time to view cancer as “wounds that do not heal”, and act accordingly!
In this short piece with Tosca Dalessi, we explore how oncoembryonic programs could reshape precision therapy:
— Less collateral damage
— Prevent resistance
— Better models for discovery
🔗 doi.org/10.1002/ctm2...
#Postdoc position alert 🚨My friend and colleague Iros Barozzi is offering a fully funded postdoc postion studying tumor heterogeneity using functional genomics 🧬 and single cell omics 🧑🔬. great lab and great collaborators :) join our institute in beautiful Vienna.
Kudos to Cammareri and co. of Myant lab for unveiling how ATRX & HNF4A gatekeep colonic identity—lose ATRX, and cells go rogue, fueling CRC metastasis. A crucial step toward understanding and targeting plasticity in #ColorectalCancer! #CancerResearch
www.nature.com/articles/s41...
Fantastic work, congratulations Claudio and the team!
Congratulations @christophschneider.bsky.social and to the team!
Excerpt from article by Prof Kelly-Ann Allen: The index could reflect good science practices — for instance, by recognizing replication studies. And public reach could be measured in terms of open-science prac- tices — data-sharing, pre-registering protocols and commu- nicating through podcasts, blogs and media contributions. In some fields, publishing in practice-based journals could be rewarded to ensure that research reaches profes- sional communities. Similarly, editorial and peer-review work for these journals — and work for scientific societies, regardless of prestige — could be valued. Ultimately, the full list of metrics should be decided by the academic community, reflecting a collective vision for a healthier workplace. Funding bodies and institutions could then incorporate the index into their evaluation criteria, providing both the infrastructure and incentives for adoption. Many of the metrics are already tracked in existing data repositories, but improved systems to collect and amalgamate the data are needed. The index should remain dynamic and evolving, allowing new ways to evaluate and measure other desirable work- place attributes to emerge over time — work–life balance, for instance, or a positive teaching culture.
Move beyond ‘publish or perish’ by measuring behaviours that benefit academia
Perspective in #Nature 🧪 suggesting a new "G+ index" — G representing generosity, giving and other ‘good things’ in academia
Wouldn't this be great 🤔
By Prof. Kelly-Ann Allen
www.nature.com/articles/d41...
By 2030, 1 in 3 colorectal cancers will occur before age 50! The speed at which early-onset colorectal cancer metastasizes remains unclear, but understanding its biology is urgent to prevent a looming cancer epidemic.
www.cell.com/cell/fulltex...
Today is #WorldCancerDay, a day to reflect and push for progress.
Cancer affects millions, but research and innovative treatments are changing lives. Every discovery, every breakthrough, and every act of support brings us closer to a future where cancer is no longer a life-threatening disease.
Congratulations Bahar and team!
Exciting new findings reveal eosinophils as key allies in the fight against colorectal cancer by blocking tumor spread.
Great work by Kristina Handler, Deeksha Raju, Alessandra Gurtner & team lead by the amazing Isabelle Arnold! Honored to be a part of this study.
www.biorxiv.org/content/10.1...
Honored that our story on Plexin B2 was mentioned alongside these amazing studies! 🥰
aacrjournals.org/cancerdiscov...
Great, would love to join as well, thanks!
A growth, and then a metastasis, of cancer researchers (two starter packs)...
by @johannajoyce.bsky.social
bsky.app/starter-pack...
bsky.app/starter-pack...
Hello friends!
Thrilled to join the Bluesky community! My research delves into the connections between embryonic development and cancer, using a novel approach we call 'oncoembryology'.
Check out our latest preprint: www.biorxiv.org/content/10.1...
And our review: www.nature.com/articles/s41...
